General tumor cell population

The general tumor cell population refers to the heterogeneous assembly of malignant cells that constitute a cancerous growth, characterized by the "hallmarks of cancer" including sustained proliferative signaling, evasion of growth suppressors, and resistance to cell death (Hanahan & Weinberg, 2011, Cell). Unlike specific molecular targets such as the EGFR receptor or the BRAF enzyme, this term describes the cellular entity as a whole, which serves as the broad target for conventional oncology treatments (National Cancer Institute, 2023). These cells typically exhibit genomic instability and high metabolic demands, which are exploited by cytotoxic agents to induce apoptosis or mitotic catastrophe (NIH, 2022). However, the inherent genetic and phenotypic diversity within a single tumor cell population often leads to the selection of resistant clones during therapy, presenting a significant challenge for long-term clinical efficacy (PubMed, PMC4106027). Consequently, while traditional therapies aim to reduce the overall tumor cell population, modern precision medicine seeks to identify specific vulnerabilities within these cells to improve therapeutic indices and patient outcomes.

Other names

Cancer cellsMalignant cellsNeoplastic cellsTumor cellsMalignant neoplasm

Non-specific induction of cytotoxicity and apoptosis through DNA damage, inhibition of DNA synthesis, or disruption of microtubule dynamics during mitosis (NIH, 2022).